CARIS LIFE SCIENCES, INC. Interest Expense Nonoperating
CARIS LIFE SCIENCES, INC. (CAI) reported Interest Expense Nonoperating of $9.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $9.23M, a 51.96% decline year-over-year.
- CARIS LIFE SCIENCES, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $12.81M, a 0.21% increase year-over-year.
- CARIS LIFE SCIENCES, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $11.36M, a 14.37% decline year-over-year.
- CARIS LIFE SCIENCES, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $13.51M, a 2.12% decline year-over-year.
- CARIS LIFE SCIENCES, INC. interest expense nonoperating for fiscal 2025 was $56.85M, a 13.65% increase from fiscal 2024.
- CARIS LIFE SCIENCES, INC. interest expense nonoperating for fiscal 2024 was $50.02M, a 58.26% increase from fiscal 2023.
- CARIS LIFE SCIENCES, INC. interest expense nonoperating for fiscal 2023 was $31.61M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.23M 10-Q · filed 2026-08-05 | $22.04M 10-Q · filed 2026-08-05 | $33.39M derived: sum of 3 quarters · filed 2026-08-05 | $46.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $12.81M 10-Q · filed 2026-05-08 | $24.16M derived: sum of 2 quarters · filed 2026-05-08 | $37.67M derived: sum of 3 quarters · filed 2026-05-08 | $56.88M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $24.86M derived: sum of 2 quarters · filed 2026-03-03 | $44.07M derived: sum of 3 quarters · filed 2026-08-05 | $56.85M 10-K · filed 2026-03-03 |
| 2025-09-30 | $13.51M 10-Q · filed 2025-11-05 | $32.72M derived: sum of 2 quarters · filed 2026-08-05 | $45.50M 10-Q · filed 2025-11-05 | $58.76M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $19.21M 10-Q · filed 2026-08-05 | $31.99M 10-Q · filed 2026-08-05 | $45.25M derived: sum of 3 quarters · filed 2026-08-05 | $59.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $12.78M 10-Q · filed 2026-05-08 | $26.04M derived: sum of 2 quarters · filed 2026-05-08 | $39.84M derived: sum of 3 quarters · filed 2026-05-08 | $53.52M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $13.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $27.06M derived: sum of 2 quarters · filed 2026-03-03 | $40.73M derived: sum of 3 quarters · filed 2026-03-03 | $50.02M 10-K · filed 2026-03-03 |
| 2024-09-30 | $13.80M 10-Q · filed 2025-11-05 | $27.47M derived: sum of 2 quarters · filed 2025-11-05 | $36.76M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $13.67M 10-Q · filed 2025-08-12 | $22.96M 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | $31.61M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |